Literature DB >> 1562278

The properties of total adducts and interstrand crosslinks in the DNA of cells treated with CB 1954. Exceptional frequency and stability of the crosslink.

F Friedlos1, J Quinn, R J Knox, J J Roberts.   

Abstract

CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide) becomes, upon bioactivation, a difunctional alkylating agent. It can be up to a 100,000-fold more cytotoxic in cells that are able to bioactivate it than in those that cannot. This increase in cytotoxicity is much greater than would be predicted from the conversion of a monofunctional alkylating agent to a difunctional one. We now show that the interstrand crosslink formed in the DNA of CB 1954-sensitive cells has some unusual properties. In Walker cells, which are able to activate CB 1954, the interstrand crosslink is the major adduct and can constitute up to 70% of the total adducts. These crosslinks are only poorly excised, as are those produced in V79 cells (which are themselves unable to activate CB 1954) by co-culturing them with Walker cells. Also, CB 1954 is approximately 10-fold more reactive toward the DNA of Walker cells than V79 cells. These observations may explain the extent of the increase in cytotoxicity accompanying the bioactivation of CB 1954.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562278     DOI: 10.1016/0006-2952(92)90499-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Superhelical torsion controls DNA interstrand cross-linking by antitumor cis- diamminedichloroplatinum(II).

Authors:  O Vrána; V Boudný; V Brabec
Journal:  Nucleic Acids Res       Date:  1996-10-15       Impact factor: 16.971

Review 2.  The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).

Authors:  R J Knox; F Friedlos; M P Boland
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

Review 3.  Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs).

Authors:  W A Denny; W R Wilson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

4.  A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].

Authors:  Prashant Patel; J Graham Young; Vivien Mautner; Daniel Ashdown; Sarah Bonney; Robert G Pineda; Stuart I Collins; Peter F Searle; Diana Hull; Elizabeth Peers; John Chester; D Michael Wallace; Alan Doherty; Hing Leung; Lawrence S Young; Nicholas D James
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

5.  E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.

Authors:  S O Vass; D Jarrom; W R Wilson; E I Hyde; P F Searle
Journal:  Br J Cancer       Date:  2009-05-19       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.